MetaCap

Avantor (AVTR) vs Nautilus Biotechnology (NAUT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Avantor (AVTR) has outperformed Nautilus Biotechnology (NAUT) over the past year, gaining 28.8% versus a loss of 5.4%. Over five years, NAUT leads with a -56.4% price change compared with -62.5% for AVTR. Avantor is the larger company by market cap ($10.06 billion vs $270.0 million), about 37.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVTR+28.82%NAUT-5.36%
+83%+7%-69%
Nov 21, 20251 yearNov 20, 2026
AVTR-62.58%NAUT-57.68%
+26%-33%-92%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVTR versus NAUT key metrics
MetricAVTRNAUT
Share price$14.84$2.12
Market cap$10.06B$270.03M
1-day change-1.85%-2.30%
YTD return+29.49%+8.72%
1-year return+28.82%-5.36%
5-year return-62.54%-56.38%
P/E ratio (TTM)29.68—
Forward P/E16.73—
EPS (TTM)$0.50$-0.46
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$6.55B—
Revenue growth (YoY)-3.41%—
Net income (latest FY)$-530.20M$-59.00M
Gross margin32.65%—
Operating margin-3.76%—
Net margin-8.09%—
52-week high$17.45$4.31
52-week low$7.27$0.841
Distance from 52-week high-14.96%-50.81%
Analyst consensusholdnone
Avg. price target upside+16.91%+88.68%
Average volume8.77M6.25M
Shares outstanding677.62M127.37M
Employees13,500128
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Avantor is about 37.2 times larger than Nautilus Biotechnology by market value ($10.06B vs $270.03M).
  • AVTR has outperformed NAUT by 34.2 percentage points over the past year.

About Avantor

AVTR stock →

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees

About Nautilus Biotechnology

NAUT stock →

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.

Industrials · Biotechnology: Laboratory Analytical Instruments · 128 employees

AVTR vs NAUT FAQ

Which is bigger, Avantor or Nautilus Biotechnology?

Avantor (AVTR) is larger, with a market capitalization of $10.06B compared with $270.03M for Nautilus Biotechnology (NAUT).

Which stock has performed better over the past year, AVTR or NAUT?

AVTR returned +28.82% over the past 12 months, compared with -5.36% for NAUT (price return, excluding dividends). Past performance does not predict future results.

Are Avantor and Nautilus Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons